This program is currently not recruiting for the 2024-2025 academic year.


This PGY2 pharmacy residency program builds on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advances or specialized practice. PGY2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).


This dynamic specialty residency offers residents a range of learning experiences to develop critical skills in infectious diseases pharmacotherapy.  Residents work collaboratively with pharmacy preceptors and infectious diseases fellows and faculty (6 General Adult, 1 Transplant ID, 1 Hematology/Oncology ID, 1 pediatric ID consult services) to deliver and ensure optimal treatments and outcomes.  The resident will play an active role in clinical and administrative antimicrobial stewardship initiatives across all hospital departments. Trainees also play an active role in clinical and administrative antimicrobial stewardship initiatives across all hospital departments. Participation in the pharmacy department and ID division active learning opportunities (e.g. case conference, pharmacy teaching seminar, and medicine grand rounds) provides residents with tailored learning environments to excel and develop teaching and leadership skills.  Teaching experience is provided through pharmacy and ID division group discussions, pharmacy students and residents’ preceptorship, and an optional teaching certificate program at Northeastern University School of Pharmacy (optional). Finally, residents contribute to local and system-wide interdisciplinary committees pertaining to infectious diseases management, antimicrobial stewardship, and antimicrobial usage.

We currently offer one position for the PGY2 Infectious Diseases Pharmacy Residency.

Program Goals

The resident will complete the following ASHP-established outcomes:

  • Promote health improvement, wellness, and the prevention of infectious diseases.
  • Optimize the outcomes of individuals with an infectious disease by providing evidence-based, patient-centered medication therapy as an integral member of an interdisciplinary team or as an independent clinician.
  • Manage and improve anti-infective-use processes.
  • Demonstrate excellence in the provision of educational activities for health care professionals and health care professionals in training centering on optimizing anti-infective pharmacotherapy.
  • Serve as an authoritative resource on the optimal use of medications used to treat individuals with an infectious disease.
  • Demonstrate leadership and practice management skills.
  • Conduct infectious diseases pharmacy practice research.

Learning Experience

The first month of the residency is an orientation to the Department of Pharmacy, after a 1.5-day hospital orientation. Activities include competency lectures on basic clinical skills, training on the MGH computerized order entry system, and side-by-side decentralized training with clinical pharmacy preceptors. Additionally, residents will understand the structure of the Residency Learning System, which is the backbone of how residency training is put into action.

Core Learning Experiences:

  • Orientation
  • General Adult Infectious Diseases
  • Infectious Disease Specialist (attending-only team)
  • Transplant Infectious Diseases
  • Pediatric Intensive Care Unit and Pediatric Antimicrobial Stewardship
  • Antimicrobial Stewardship
  • Clinical Microbiology Laboratory and Infection Control
  • Infectious Diseases Clinical Management

Elective Learning Experiences:

  • Adult Critical Care - medical or surgical
  • Bone Marrow Transplant
  • Emergency Medicine
  • Internal Medicine
  • Drug Policy
  • Solid Organ Transplant

Longitudinal and Other Experiences:

  • Antimicrobial Stewardship
  • HIV/ID clinic
  • MUE Drug Policy
  • Outpatient Parenteral Antimicrobial Therapy
  • Emergency response with BLS/ACLS certification
  • Pharmacy practice experience: decentralized clinical operations
  • Research project and manuscript development
  • Residents teaching seminar / teaching certificate at Northeastern University School of Pharmacy (optional)
  • Resident officer positions
  • Development of accredited continuing education

Past and Current Residents

2017 – 2018

Samantha Steiger, PharmD, BCIDP
Medical Science Liaison
Takeda Pharmaceutical Company Limited

2018 – 2019

Meagan Adamsick O’Brien, PharmD, BCIDP
Clinical Pharmacy Specialist – Infectious Diseases
Novant Health – Presbyterian Medical Center, Charlotte, NC

2019 – 2020

Kelsey Williams, PharmD, BCIDP
Infectious Diseases Clinical Pharmacy Specialist
Baptist Hospital of Miami, Miami, FL

2021 – 2023 Non-Traditional Resident

Miranda Monk, PharmD, BCPS, BCIDP
Medical Science Liaison
Ferring Pharmaceuticals

2022 – 2023

Sarah Valiante, PharmD
Infectious Diseases Clinical Pharmacy Specialist
Hackensack Meridian Health - Jersey Shore University Medical Center

Contact Information

Ramy Elshaboury, PharmD, BCPS, BCIDP
Director, Clinical Pharmacy Services
Director, PGY2 Infectious Diseases Pharmacy Residency
Twitter: @mgh_ast